Application of ferroptosis-related genes in prognostic assessment of diffuse large B-cell lymphoma
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY
- Publication Date
- 2022-06-28
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of disease prognosis and molecular biology, and particularly relates to the application of ferroptosis-related genes in the prognosis evaluation of diffuse large B-cell lymphoma. Background technique
[0002] The information disclosed in this Background section is only for enhancement of understanding of the general background of the invention and should not necessarily be taken as an acknowledgement or any form of suggestion that this information forms the prior art already known to a person of ordinary skill in the art.
[0003] Diffuse large B-cell lymphoma (DLBCL) is a malignant and aggressive tumor derived from B-lineage lymphocytes, accounting for 30β40% of non-Hodgkin lymphomas. DLBCL is a highly heterogeneous lymphoid tumor with variations in gene expression profiles and altered genetic information. Currently, R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) is the most...